Inventor · disambiguated record
Adrian Philip Kells
Also filed as: KELLS ADRIAN P · KELLS ADRIAN PHILIP
12 granted patents·14 pending applications·37 citations·filing 2010–2025
89Inventor score
Files withVOYAGER THERAPEUTICS INC17UNIV CALIFORNIA7ASKLEPIOS BIOPHARMACEUTICAL INC1BANKIEWICZ KRYSTOF1
Top patents by PatentIndex Score
26 records- 0194US10335466B2AADC polynucleotides for the treatment of parkinson's diseaseVOYAGER THERAPEUTICS INC·Filed 2015·Granted Jul 2, 2019·11 cites·14 claims
- 0292US11027000B2AADC polynucleotides for the treatment of Parkinson's diseaseVOYAGER THERAPEUTICS INC·Filed 2019·Granted Jun 8, 2021·4 cites·26 claims
- 0390US10426375B2Methods for biomedical targeting and delivery and devices and systems for practicing the sameUNIV CALIFORNIA·Filed 2018·Granted Oct 1, 2019·6 cites·16 claims
- 0489US10426374B2Methods for biomedical targeting and delivery and devices and systems for practicing the sameUNIV CALIFORNIA·Filed 2018·Granted Oct 1, 2019·5 cites·25 claims
- 0588US11298043B2Methods for biomedical targeting and delivery and devices and systems for practicing the sameUNIV CALIFORNIA·Filed 2019·Granted Apr 12, 2022·6 cites·25 claims
- 0688US2024415943A1Aadc polynucleotides for the treatment of parkinson's diseaseVOYAGER THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0784US2025288219A1Methods for Biomedical Targeting and Delivery and Devices and Systems for Practicing the SameUNIV CALIFORNIA·Filed 2025·Application pending·0 cites
- 0878US12318183B2Methods for biomedical targeting and delivery and devices and systems for practicing the sameUNIV CALIFORNIA·Filed 2022·Granted Jun 3, 2025·0 cites·13 claims
- 0978US2024285667A1Central nervous system targeting polynucleotidesVOYAGER THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1077US11975056B2AADC polynucleotides for the treatment of Parkinson's diseaseVOYAGER THERAPEUTICS INC·Filed 2021·Granted May 7, 2024·0 cites·24 claims
- 1175US12370270B2Methods for distributing high levels of therapeutic agent throughout the cortex to treat neurological disordersUNIV CALIFORNIA·Filed 2022·Granted Jul 29, 2025·0 cites·10 claims
- 1275US11305022B2Methods for distributing high levels of therapeutic agent throughout the cortex to treat neurological disordersBANKIEWICZ KRYSTOF·Filed 2010·Granted Apr 19, 2022·2 cites·13 claims
- 1374US11497576B2Trajectory array guide systemVOYAGER THERAPEUTICS INC·Filed 2018·Granted Nov 15, 2022·2 cites·40 claims
- 1474US11298041B2Methods for biomedical targeting and delivery and devices and systems for practicing the sameUNIV CALIFORNIA·Filed 2017·Granted Apr 12, 2022·1 cites·23 claims
- 1571US2025090197A1Cannula system and use thereofVOYAGER THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1670US2019008933A1Aadc polynucleotides for the treatment of parkinson's diseaseVOYAGER THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1770US2019008931A1Aadc polynucleotides for the treatment of parkinson's diseaseVOYAGER THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1870US2019008932A1Aadc polynucleotides for the treatment of parkinson's diseaseVOYAGER THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1965US2025222072A1Methods and compositions for the treatment of parkinson's diseaseASKLEPIOS BIOPHARMACEUTICAL INC·Filed 2023·Application pending·0 cites
- 2065US2019365793A1Central nervous system targeting polynucleotidesVOYAGER THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2159US2019054158A1Compositions and methods for the treatment of aadc deficiencyVOYAGER THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 2258US12319929B2Compositions and methods for the treatment of Parkinson's diseaseVOYAGER THERAPEUTICS INC·Filed 2019·Granted Jun 3, 2025·0 cites·19 claims
- 2354US2018021364A1Central nervous system targeting polynucleotidesVOYAGER THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2453US2021361318A1Cannula system and use thereofVOYAGER THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2552US2019000940A1Compositions and methods for the treatment of aadc deficiencyVOYAGER THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2640US2019055578A1Delivery of central nervous system targeting polynucleotidesVOYAGER THERAPEUTICS INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Adrian Philip Kells files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →